Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

PurposeTo compare the efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy (PCV) over 96 weeks in the HAWK study.DesignHAWK was a global, 2-year, randomised, double-masked, multicentre phase III trial in participants with neovascular age-related macul...

Full description

Bibliographic Details

Published in:	British journal of ophthalmology Vol. 106; no. 7; pp. 994 - 999
Main Authors:	Ogura, Yuichiro, Jaffe, Glenn J, Cheung, Chui Ming Gemmy, Kokame, Gregg T, Iida, Tomohiro, Takahashi, Kanji, Lee, Won Ki, Chang, Andrew A, Monés, Jordi, D’Souza, Divya, Weissgerber, Georges, Gedif, Kinfemichael, Koh, Adrian
Format:	Journal Article
Language:	English
Published:	BMA House, Tavistock Square, London, WC1H 9JR BMJ Publishing Group Ltd 01.07.2022 BMJ Publishing Group LTD BMJ Publishing Group
Subjects:	Clinical outcomes Clinical Science clinical trial Diabetic retinopathy Drug therapy Eye diseases Immunotherapy Monoclonal antibodies Patient safety retina Side effects Vein & artery diseases Japan
ISSN:	0007-1161, 1468-2079, 1468-2079
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!